Risks and Complications of Limb Lengthening Surgery

Limb lengthening is used in very different clinical situations. Medically indicated lengthening and cosmetic bilateral limb lengthening share the same biological principle, distraction osteogenesis, but they begin from different clinical circumstances and should not be viewed as the same treatment.

Medically indicated limb lengthening may form part of treatment for an existing structural or functional problem. This includes Leg Length Discrepancy (LLD) and Growth Plate Arrest, as well as congenital limb differences such as Congenital Femoral Deficiency, Fibular Hemimelia and Tibial Hemimelia. Lengthening may also have a selected role in Skeletal Dysplasias, including Achondroplasia.

When shortening exists alongside deformity, lengthening may be incorporated into treatment for conditions such as Blount Disease, Rickets-Related Limb Deformities, Bow Legs or Knock Knees, depending on the individual anatomy and the presence of a genuine limb length difference. In acquired and reconstructive cases, it may form part of treatment for Fracture Malunion and Post-Traumatic Deformity, Bone Defects After Trauma, Tumour or Infection, Bone Nonunion, Osteomyelitis and Fracture-Related Infection, Congenital Pseudarthrosis of the Tibia or a wider Complex Post-Traumatic Reconstruction plan.

The same principles can be applied in selected Upper Limb Lengthening and Brachymetatarsia cases, although the anatomy, functional goals and treatment demands are different.

In all of these settings, lengthening is considered within the wider condition of the limb. Alignment, joint stability, deformity, growth, bone and soft-tissue quality and useful function may matter as much as the amount of length gained.

Cosmetic limb lengthening is different. In this setting, bilateral lower-limb lengthening is performed in an otherwise healthy person over 155 cm in height for elective height gain, rather than to correct an existing pathological limb-length problem.

The biological principles overlap, and many of the same complications can occur in both settings. The clinical starting point, however, is fundamentally different. A patient undergoing reconstructive lengthening already has a condition that treatment is intended to improve. In cosmetic limb lengthening, the patient is ordinarily healthy, walks normally and has no functional disorder of the limbs before treatment begins.

That distinction matters when risk is discussed.

This guide therefore focuses primarily on cosmetic limb lengthening, while recognising that many of the biological, mechanical and rehabilitation principles described also apply more broadly to limb lengthening.

The clinical reality of cosmetic limb lengthening

Cosmetic limb lengthening begins with an unusual clinical reality.

The procedure is usually performed on a person who is healthy, walks normally and has no functional disorder of the limbs. For a period of time, surgery and treatment will reduce that person’s mobility, independence and physical capacity.

The clinical responsibility is therefore not simply to make the bones longer. It is to return the patient to normal life with the length gained, the bones united, the joints moving and the ability to walk at least as well as before.

This is the standard by which the result should be assessed.

A technically successful operation is not enough. Reaching a planned number of centimetres is not enough. Even complete bone union is not enough if the patient is left with a stiff joint, persistent nerve symptoms, chronic pain, poor balance or an abnormal gait.

Cosmetic limb lengthening must therefore be approached as a complete orthopaedic treatment. The operation is only one part of it. Bone regeneration, muscle adaptation, joint movement, nerve function, implant performance, physiotherapy, nutrition, psychological resilience and social support all influence the final result.

Many appropriately selected patients complete this treatment successfully. Complications can nevertheless occur despite careful planning, experienced surgery and good patient participation. Some can be corrected with relatively limited measures. Others may prolong treatment, require another operation, reduce the intended lengthening or, in uncommon circumstances, leave a permanent impairment.

The purpose of this guide is neither to discourage nor to reassure. It is to explain the treatment honestly.

How limb lengthening works

The central biological process in limb lengthening is called distraction osteogenesis.

During surgery, the bone is divided through a controlled osteotomy. After a short latency period, the two bone surfaces are gradually separated by the lengthening system. The body forms new bone within the developing gap. This new tissue is called the regenerate.

As distraction continues, the regenerate must develop while the muscles, tendons, fascia, nerves, blood vessels and skin adapt to the increasing length. The joints above and below the bone must remain mobile and stable.

Once distraction has ended, the regenerate enters consolidation. During this stage, the new bone gradually becomes stronger and assumes more of the mechanical load from the implant.

Distraction osteogenesis is a remarkable biological capacity, but it is not unlimited. The rate of lengthening, stability of the bone, blood supply, alignment, nutrition, mechanical loading and individual healing response must remain compatible with one another throughout treatment.

What is meant by a complication?

Complication reporting in limb lengthening is not consistent.

Some publications count only events that require another operation. Others also include temporary joint stiffness, delayed bone formation, pin site problems or changes to the treatment plan. Complications may be reported per patient, per bone, per implant or per individual event. Follow-up periods also differ considerably.

Limb reconstruction research also uses specific terminology that can make the results appear less eventful than the treatment actually was.

In a commonly used framework, an event that resolves without an unplanned operation may be classified as a problem. An event that requires an unplanned operative intervention but ultimately resolves may be called an obstacle. The term complication may be reserved for an event that creates new pathology, prevents the treatment goal from being achieved or leaves a lasting consequence.

This distinction is useful when comparing research. It does not describe the full burden experienced by the patient. An obstacle may still mean another anaesthetic, further incisions, delayed rehabilitation and a longer recovery. A publication can therefore report few lasting complications while still containing a clinically important number of problems and additional procedures.

For this reason, a single percentage cannot accurately describe the risk for every patient.[1–3]

In this clinical framework, an event must be taken seriously as a complication if it:

• prevents the patient from returning to the previous quality of walking and limb function
• substantially changes the planned treatment
• requires an unplanned intervention
• prevents the intended treatment goal from being reached
• creates a new medical problem
• leaves a continuing functional impairment

This does not mean that every episode of pain or swelling is abnormal. It means that expected symptoms must still be observed in context.

Pain may be part of recovery, but it may also indicate excessive soft tissue tension, infection, nerve irritation, fracture or an implant problem. The same applies to swelling, stiffness and weakness.

The correct question is not simply whether a symptom is common. The question is whether it is following the expected course for that particular patient.

This is not a one-day treatment

Patients sometimes think of cosmetic limb lengthening as an operation followed by several weeks of recovery. That is not an accurate picture.

The treatment has several stages:

1. Surgery and the early postoperative period
2. A short latency period before lengthening begins
3. Gradual distraction of the bone
4. Consolidation of the newly formed bone
5. Recovery of strength, movement and gait
6. Removal of the implant when required
7. Further rehabilitation after removal

The complete process may extend to a year or longer. For some patients, functional recovery and implant removal can take considerably more time.[2,3]

A patient must therefore prepare for more than the hospital admission. Work, education, housing, transport, physiotherapy, nutrition, family responsibilities and day-to-day assistance all need to be considered.

A person whose income depends on physical work should not assume that normal employment will continue during treatment. Even working from home can become difficult when pain, physiotherapy, sleep disturbance, medical appointments and reduced mobility are added to the working day.

The same applies to social support. Depending on one friend or one relative for an extended period is not always sufficient. Circumstances change. A sensible plan includes a primary support person and an alternative source of help.

This preparation is not separate from medical safety. It is part of it. When the practical structure around the patient begins to fail, physiotherapy may be missed, nutrition may deteriorate, appointments may be delayed and pressure to return prematurely to normal life may increase.

Once the process begins, it cannot simply be reversed

Another misunderstanding is that a patient can begin lengthening, change their mind and immediately return to normal.

Even if distraction is stopped at an early stage, the osteotomy still has to heal. The regenerate must consolidate. Mobility restrictions and rehabilitation continue. The implant remains in the bone until it is appropriate to remove it.

Stopping further lengthening may be possible.

Undoing the entire biological and surgical process is not.

A patient should understand this before treatment begins.

A radiograph is not the patient

Radiographs are indispensable during limb lengthening. They provide information about distraction, regenerate formation, alignment, implant position and the progress of bone healing.

They do not show everything.

As the bone gradually becomes longer, the muscles, tendons, fascia, nerves, blood vessels and skin must adapt. The joints above and below the lengthened bone are exposed to changing forces. Muscle balance changes. The mechanical axis may change. The patient’s gait and ability to control the limb also change.

The body does not adapt at exactly the same rate in every patient.

A regenerate may look satisfactory while the knee is gradually losing movement. A radiograph may show the intended amount of distraction while a nerve is becoming increasingly sensitive to stretch. An implant may be functioning normally while the patient is developing an equinus position at the ankle.

An X-ray cannot adequately demonstrate how stiff a joint has become, how the patient is walking, whether muscle strength is declining, whether a neurological symptom is progressing or whether rehabilitation is beginning to fail.

This is why follow-up based only on radiographs is insufficient.

Clinical examination must assess joint movement, muscle tension, neurological function, swelling, wound condition, walking capacity and the patient’s ability to continue rehabilitation.

Remote review can support treatment, particularly for international patients. Distance itself is not necessarily the problem. The problem arises when clinical follow-up becomes little more than the exchange of radiographic images.

Remote review cannot replace every necessary physical examination.

Bone formation and healing complications

Poor or delayed regenerate formation

New bone should develop progressively within the distraction gap.

In some patients, the regenerate appears less dense, less organised or slower to mature than expected. Possible contributing factors include age, bone quality, blood supply, previous surgery, the position of the osteotomy, the distraction rate, instability, infection, nicotine exposure, nutritional deficiencies and individual healing biology.

Delayed regenerate formation does not always mean failure. It does mean that the treatment needs to be reassessed.

The distraction rate may need to be reduced or paused. Weight bearing may need to change. Nutrition and metabolic factors may require further investigation. The consolidation period may become longer than originally expected.

If bone formation remains inadequate, additional treatment may be required. This can include bone grafting, correction of the mechanical environment or revision of the implant.

Delayed union and nonunion

Delayed union means that the new bone is taking longer than expected to become structurally mature. Nonunion means that satisfactory union is unlikely without further intervention.

These conditions prolong restricted mobility and expose the implant to repeated mechanical stress. An implant is designed to support the limb during healing. It is not intended to carry the full mechanical burden indefinitely in the absence of bone union.

Management depends on the reason for poor healing. It may include modification of loading, correction of nutritional or metabolic problems, investigation for infection, compression of the regenerate, bone grafting or revision of the fixation.[3,4]

Premature consolidation

The opposite problem can also occur.

Premature consolidation means that the osteotomy begins to unite too firmly before the intended length has been achieved. This may follow a delay or interruption in distraction, an ineffective distraction mechanism, an unsuitable distraction rate or particularly active bone formation.

If recognised early, the protocol may be adjusted. If the osteotomy has completely consolidated, another operation may be needed before lengthening can continue.

With externally controlled internal nails, correct use of the controller must be confirmed. A completed controller session does not prove that the implant has lengthened by the intended amount. Actual distraction must be checked clinically and radiographically.

Regenerate deformity and loss of alignment

Muscles do not pull equally in every direction. As distraction progresses, these forces can gradually alter the position of the bone.

Possible changes include:

• varus or valgus deviation
• forward or backward angulation
• rotational change
• translation of the bone segments
• asymmetric lengthening
• loss of alignment during consolidation

Implant position, osteotomy level, bone geometry and muscle balance all influence this risk.

Preoperative planning should evaluate the mechanical axis of the complete limb, not only the position of the implant within one bone. During treatment, serial imaging is used to identify an alignment change before it becomes fixed.

Additional screws, modified loading, adjustment of the lengthening plan or corrective surgery may be required.

Tibial lengthening and the fibula

Femoral and tibial lengthening are not interchangeable operations.

During tibial lengthening, the fibula must also be managed correctly. The tibia and fibula form a functional unit, with important relationships at both the knee and ankle. The operative plan must account for the fibula, including the level of the fibular osteotomy and the need to control its position during lengthening.

Unintended relative migration between the tibia and fibula can alter joint mechanics. Depending on the direction and extent of the change, it may contribute to ankle problems, disturbance of the proximal or distal tibiofibular relationship, contracture, subluxation or loss of alignment.[5]

Tibial lengthening also places particular demands on ankle dorsiflexion, calf and Achilles flexibility, foot position and monitoring of the common peroneal nerve.

The choice between femoral and tibial lengthening should therefore not be reduced to which bone appears capable of producing more centimetres. Anatomy, limb proportions, soft tissues, alignment, implant suitability and rehabilitation all need to be considered.

Fracture and regenerate collapse

The regenerate remains vulnerable until it has matured sufficiently.

A fall, excessive loading or premature return to activity may cause a fracture or deformity. Fractures can also occur around locking screws, through the regenerate or after implant removal.

The stated mechanical capacity of an implant is not the same as the biological strength of the healing bone. An implant may tolerate a particular load while the regenerate is not yet ready for it.

Weight bearing must therefore be prescribed according to the implant, its diameter, the patient’s weight, the radiographic quality of the regenerate and the stage of healing.

A fracture may require protection, casting, further fixation, implant revision or bone grafting.

Overlengthening, underlengthening and asymmetry

The final length may differ from the original target.

This can occur because of differences between the two limbs, implant performance, alignment concerns, poor regenerate quality, joint restriction or neurological symptoms. It may also be a deliberate clinical decision to stop before the original target.

A reduced target is not necessarily a failed treatment.

If continuing would place joint movement, nerve function or bone healing at unacceptable risk, stopping earlier may be the correct decision.

There is no guaranteed number of safe centimetres

Patients often arrive with a fixed number in mind.

They may have organised their time, finances and expectations around reaching that number. Understandably, they do not want to stop after investing so much in the process.

However, the maximum travel of an implant is not the same as the safe lengthening capacity of a patient.

Preoperative assessment can examine anatomy, flexibility, bone quality and general health. It can establish a clinically reasonable plan. What cannot be known with certainty is how that patient’s regenerate, muscles, joints and nerves will respond several centimetres into distraction.

The safe amount becomes clearer during treatment.

If the bone is forming well, joint movement is preserved, the muscles remain responsive and the patient is completing physiotherapy, the original target may remain appropriate. If the regenerate deteriorates, the knee or ankle loses movement, or neurological symptoms appear, the target may need to change.

Patients should therefore prepare for a clinically reasonable range rather than an absolute promise.

The objective is not to extract every possible millimetre from the implant. It is to achieve the greatest responsible length while preserving function.

Joint, muscle and tendon complications

Joint stiffness and contracture

Muscles and tendons do not always adapt as quickly as the bone is lengthened. Increasing tension can progressively restrict joint movement.

During femoral lengthening, particular attention is given to the hip flexors, quadriceps and knee. During tibial lengthening, the calf muscles, Achilles tendon and ankle require close monitoring.

Loss of ankle dorsiflexion may lead to an equinus position, in which the foot tends to point downwards. Loss of knee movement can affect walking, sitting, transfers and rehabilitation.

A contracture rarely appears as a sudden event. It usually develops gradually. This is why range of motion should be measured repeatedly rather than judged from the patient’s general appearance or radiograph.

Treatment may involve:

• adjustment of the distraction rate
• a temporary pause
• changes in resting position
• more intensive supervised physiotherapy
• splinting or bracing
• reduction of the planned lengthening
• soft tissue surgery in selected cases

Physiotherapy is not an optional service added after the operation.

It is part of the treatment itself.

Joint subluxation or dislocation

Lengthening changes the forces acting across the joints. If there is pre-existing instability, abnormal anatomy or a marked imbalance of muscle forces, a joint may begin to lose its normal relationship.

Subluxation means partial loss of joint alignment. Dislocation means complete loss.

These are more serious than ordinary stiffness and may require an immediate change in the treatment plan, bracing or surgery.

The hip, knee, ankle and foot must therefore be assessed as parts of the same mechanical system.

Muscle weakness and altered gait

Weakness develops because of surgery, reduced loading, pain, disuse and the changing relationship between muscle length and tension.

Patients may experience difficulty controlling the legs, rising from a chair, using stairs or maintaining balance. Endurance falls. Walking may initially require a frame, walker or crutches.

Bone union alone does not restore these functions.

Strength, balance, joint control and gait must be rebuilt through rehabilitation.

The patient’s original walking pattern is the reference. A few additional centimetres cannot compensate for a lasting functional loss.

Nerve complications

Nerves may be affected by direct injury, compression or gradual stretch.

Symptoms can include:

• tingling
• numbness
• burning or electric pain
• increased sensitivity
• pain radiating into the foot
• weakness in a particular muscle group
• difficulty lifting the foot or toes

Temporary disturbance of nerve function may recover when the cause is recognised and tension is reduced. Progressive weakness or sensory loss requires prompt assessment.[6]

Depending on the findings, distraction may need to be slowed, paused or partially reversed. Limb position may be changed. Compression may need to be investigated. In selected cases, surgical release of the nerve is required.

New weakness should never be accepted as a routine part of lengthening.

Continuing distraction despite a deteriorating neurological examination can turn a reversible problem into a lasting one.

Vascular and thromboembolic complications

Bleeding and vascular injury

Blood vessels may be injured during osteotomy, reaming, implant insertion or placement of locking screws.

Bleeding may remain localised as a haematoma. More substantial bleeding may require transfusion, vascular assessment or surgical treatment.

A foot that becomes pale, cold, blue, unusually painful or poorly perfused requires urgent evaluation.

Deep vein thrombosis and pulmonary embolism

Major bilateral lower-limb surgery, reduced mobility, higher body weight and long-distance travel can increase concern for venous thrombosis.

A deep vein thrombosis is a clot within a deep vein, usually in the leg. If part of the clot travels to the lungs, it can cause a pulmonary embolism.

Limb-lengthening-specific evidence is limited and practice varies. Preventive treatment must therefore be selected according to the individual patient’s clotting and bleeding risks. Medication, mechanical prevention and safe early mobilisation may all be used. These measures reduce risk but cannot remove it completely.[7]

New calf swelling, chest pain, unexplained shortness of breath, coughing blood, fainting or a sudden rapid heartbeat requires urgent medical assessment.

Compartment syndrome

Compartment syndrome occurs when pressure rises within a closed muscle compartment and compromises circulation and nerve function.

Severe pain out of proportion to the expected recovery, increasing limb tightness, pain when the muscles are gently stretched, progressive numbness or weakness may indicate this condition.

Acute compartment syndrome is a surgical emergency.

Fat embolism

Procedures involving the bone and medullary canal can release fat and marrow material into the circulation.

Fat embolism syndrome is a recognised but poorly standardised clinical entity in orthopaedic practice. Its incidence in elective cosmetic limb lengthening cannot be estimated reliably from current evidence. It can nevertheless be serious.

Respiratory difficulty, neurological change or unexplained deterioration after surgery requires immediate medical assessment.[8]

Infection

Surgical wound infection

A superficial infection may affect the skin or incision. Increasing redness, warmth, pain, drainage or separation of the wound should be assessed.

A deep infection may involve muscle, the implant or bone. Infection involving bone is known as osteomyelitis.

Deep infection may require cultures, targeted antibiotics, surgical debridement and, in some cases, revision or removal of the implant.

Pain relief can improve symptoms. It does not treat the infection itself.

Pin site infection

Lengthening over nail and other methods involving an external fixator require pins or wires to pass through the skin and soft tissues into bone.

These pin sites create an infection risk that does not exist in the same form with a fully internal nail. Infection may occur despite appropriate hygiene. Local mechanics, soft-tissue conditions and the duration of fixation are clinically relevant, while evidence linking individual host factors to pin-site infection remains limited and inconsistent.[9]

Pin site problems should not automatically be attributed to poor patient care.

Increasing pain, drainage, spreading redness, pin loosening or systemic illness may require antibiotics, replacement of a pin, adjustment of the frame or further surgery.

Implant and device complications

Every implant is a foreign object with a defined mechanical capacity.

This applies to lengthening over nail, PRECICE, FITBONE, newer weight-bearing nails and every other internal or external system.

No implant is infinitely strong.

Implant selection

Not every nail is suitable for every patient.

The medullary canal must be able to accept an implant with an appropriate diameter. The implant must also be considered in relation to the patient’s body weight, bone geometry and expected loading.

Whenever possible, a mechanically appropriate nail diameter is preferred. At the same time, the canal should not be excessively reamed merely to place a larger implant. Excessive removal of internal bone can introduce another form of biological and mechanical risk.

Implant selection is therefore a balance.

A thicker nail is not automatically better if achieving that diameter requires avoidable damage to the bone.

Mechanical failure

If bone healing is delayed, the implant remains responsible for carrying repeated loads for longer than intended.

Possible problems include:

• failure of the distraction mechanism
• unintended shortening or backtracking
• jamming
• bending of the nail
• fracture of the nail
• loosening or breakage of locking screws
• loss of fixation
• loss of alignment
• failure of the external controller
• incomplete or inaccurate distraction

Some problems can be corrected by checking controller position or modifying the protocol. Others require another operation.[3,4]

A patient should also understand that a procedure initially performed through small incisions may require larger or additional incisions if the nail breaks, the bone does not unite or revision after limb lengthening or reconstruction becomes necessary.

Weight bearing is a clinical prescription

The ability of a patient to walk after surgery depends on more than whether an implant is described as weight bearing.

The nail diameter, patient weight, bone quality, regenerate strength, stage of treatment and type of movement all matter. Standing from a chair, turning, stumbling and climbing stairs generate different bending, rotational and shear forces.

A patient who is permitted to place more weight through the limb is not automatically permitted to run, jump, lift heavy weights or exercise without restriction.

Too much loading can damage the implant or immature bone. Excessive restriction can also create problems through weakness, poor mobility and increased thrombotic risk.

Weight bearing is therefore a dose.

It must be adjusted throughout treatment.

Newer does not automatically mean safer

New implant designs can improve patient comfort, distraction control and mechanical capacity. They can also introduce failure patterns that only become apparent after sufficient numbers of patients have completed distraction, consolidation, implant removal and functional recovery.

A stronger implant should not be regarded as permission for unrestricted recovery.

Laboratory testing is important, but the human body produces combinations of bending, rotation and shear that cannot be represented by one static weight limit. Early clinical experience must be interpreted cautiously.

The appropriate question is not whether a new device sounds more advanced.

It is whether there is sufficient clinical evidence to understand how it behaves throughout the complete treatment.

Technology should provide greater control.

It should not reduce clinical caution.

Internal nails and external fixation do not share the same risks

Fully internal nails avoid pin tracts and reduce several difficulties associated with prolonged external frame use. They can improve comfort and make clothing, sleep and daily care easier.

They do not remove the biological demands of lengthening.

Joint contracture, poor bone formation, nerve stretch, loss of alignment, implant failure and the need for later removal remain possible.

Lengthening over nail and external fixation methods introduce additional issues:

• pin site irritation and infection
• pin or wire loosening
• pin or wire breakage
• soft tissue tethering
• frame instability
• pin scars
• difficulty with daily care and sleep
• fracture or deformity after frame removal

These methods may still have appropriate indications. They should not be selected only because their initial cost is lower. The patient must understand the different recovery burden and complication profile.

The method changes the distribution of risk.

It does not eliminate risk.

Pain, swelling and sleep

Pain, bruising, swelling, weakness and disturbed sleep are expected to some degree after surgery. Muscle tension can increase during distraction, and reduced mobility can make sleep more difficult.

Pain should still be interpreted rather than automatically suppressed.

The clinical team should be informed when pain:

• changes suddenly
• becomes progressively worse
• follows a fall or mechanical event
• is associated with redness, drainage or fever
• has a burning, electric or shooting character
• is accompanied by weakness or numbness
• prevents physiotherapy that was previously possible
• remains severe despite the prescribed treatment

Persistent neuropathic pain and complex regional pain syndrome are possible after limb surgery, although they are not expected outcomes.

Medication should be selected with attention to pain control, bleeding risk, general medical health and bone healing. Patients should not add medication, hormones or performance-enhancing substances in an attempt to accelerate recovery without medical review.

Skin and scars

Cosmetic limb lengthening leaves scars.

Internal nails require incisions for the nail entry point, osteotomy and locking screws. External methods also leave pin and wire scars. The prominence of a scar depends on skin biology, infection, tension, surgical approach and healing.

Patients understandably prefer small incisions. When treatment proceeds normally, the surgery can often be completed through relatively limited approaches.

However, the possibility of revision changes that picture.

A broken implant, nonunion, deep infection or difficult implant removal may require more incisions or a larger surgical exposure than originally planned.

Other soft tissue problems include screw irritation, local numbness, adhesions, wound healing difficulty, bursitis and sensitive scars.

Anaesthetic and general medical risks

Cosmetic limb lengthening is major orthopaedic surgery. It carries the general risks associated with anaesthesia, hospital treatment and reduced postoperative mobility.

These include:

• adverse reactions to anaesthetic or medication
• bleeding and transfusion
• infection
• blood clots
• allergic reaction to medication or implant materials
• respiratory complications
• pneumonia
• cardiac or neurological events
• unexpected admission or further medical treatment
• death

Serious systemic complications appear infrequent in published cosmetic limb-lengthening series, but inconsistent reporting and limited sample sizes prevent a dependable procedure-specific estimate.

They cannot be treated as impossible.

Patient selection

Because cosmetic limb lengthening is elective surgery in an otherwise healthy person, ILLRC applies a conservative threshold to patient selection.

Not every person seeking height gain is an appropriate candidate.

Physical condition and body weight

The patient needs sufficient strength and mobility reserve to manage walking aids, transfers and physiotherapy.

Marked obesity creates several problems at the same time. Implant selection becomes more difficult, loading increases, mobilisation may need to be restricted, and thrombotic and respiratory risks require particular assessment.

Body weight cannot be considered independently of the size of the bone and the diameter of the implant that can safely be inserted.

Age

Age affects the expected pace of bone healing and may influence muscle recovery and general physiological reserve. Contemporary internal-nail data show that bone-healing behaviour varies with age, but they do not establish a universal age cut-off.[4]

Chronological age alone should not be used as a universal rule. A healthy patient and a patient of the same age with poor bone quality or medical disease do not carry the same risk.

Nevertheless, this is elective surgery. As age and medical burden increase, the threshold for recommending treatment should become more conservative.

Medical conditions

Significant heart or lung disease, uncontrolled diabetes, vascular disease, abnormal bleeding, a tendency to excessive clotting, active infection and poor bone health may make elective cosmetic limb lengthening inappropriate.

Controlled hypertension or thyroid disease does not necessarily prevent surgery, but it adds another variable that must be assessed properly.

All medications and supplements should be reviewed. Treatment should not proceed on the assumption that a chronic condition is irrelevant simply because it is currently controlled.

Pregnancy should not overlap with distraction, consolidation or the period in which major mobility restrictions and repeated radiographs are expected. Pregnancy plans should be discussed before surgery.

Nicotine

Elective cosmetic limb lengthening is not recommended while a patient is using nicotine.

Cigarette smoking is consistently associated with higher risks of postoperative infection and nonunion across orthopaedic surgery. Evidence for vaping and other nicotine products is less mature, but it does not establish them as safe for bone regeneration or wound healing.

There is no evidence-based threshold at which a small amount of smoking or nicotine exposure can be declared safe for elective distraction osteogenesis.[10]

A sustained nicotine-free period should be established before surgery and maintained throughout bone healing.

Nutrition

Bone formation requires adequate energy, protein, vitamins and minerals.

Assessment should consider iron deficiency, vitamin D and other relevant deficiencies, malnutrition, restrictive diets and whether the patient can maintain sufficient intake during a period of increased metabolic demand.

The issue is not a particular diet label. It is whether the patient can reliably meet the nutritional requirements of major surgery and prolonged bone formation.

Current clinical evidence does not justify adding growth hormone, anabolic substances or other hormonal treatment simply in the hope of accelerating routine healing. Endocrine treatment should only be used for a recognised medical indication under appropriate specialist supervision.

Psychological and social readiness

Physical fitness is only part of candidacy.

The patient must also be prepared for reduced independence, repeated appointments, prolonged physiotherapy and a recovery that may not follow the original timetable.

Potential psychological and social effects include:

• frustration with restricted mobility
• interruption of work or education
• reduced social activity
• dependence on other people
• sleep disturbance
• anxiety about bone healing
• low mood
• isolation
• fear of complications
• pressure to continue towards an unsafe target
• disappointment when recovery takes longer than expected

Psychological assessment is not a judgement about whether the desire to be taller is valid.

It examines the stability of the decision, expectations, coping ability, body image, mental health history and available support.

Not every strong desire to increase height indicates body dysmorphic disorder. Body dysmorphic disorder is a recognised mental health condition involving a distressing and disproportionate preoccupation with perceived flaws in appearance.

It requires particular attention when concern about height has become obsessive, expectations cannot be made realistic, repeated reassurance has little effect or surgery is expected to resolve difficulties that are not caused by stature.

The specific prevalence and outcome implications of body dysmorphic disorder in cosmetic limb-lengthening patients are not well defined. Its relevance to elective appearance-altering surgery is nevertheless well established.[11]

An orthopaedic operation is not a treatment for the underlying disorder and may not relieve the associated distress. When assessment raises a meaningful concern about body dysmorphic disorder, specialist mental health evaluation should take place before surgery is considered further.

Height gain cannot guarantee a particular social, professional or emotional outcome.

A technically successful operation may not resolve difficulties that existed before surgery.

The patient should also have a realistic living and financial plan. The cost of the operation is not the only burden. Reduced working capacity, transport, rehabilitation, accommodation, nutrition and the possibility of a longer recovery all need to be anticipated.

Follow-up and rehabilitation

Close follow-up is one of the most important parts of treatment.

An international patient may understandably wish to return home soon after surgery. This should not occur before a safe clinical follow-up structure has been established.

Radiographs can show distraction, alignment and regenerate formation. They cannot fully show:

• joint contracture
• muscle tension
• declining strength
• altered gait
• early nerve dysfunction
• wound or pin site changes
• the patient’s actual ability to complete rehabilitation

Regular physical examination remains necessary.

Physiotherapy should begin early and continue through distraction and consolidation. It should address the joints above and below the osteotomy, muscle length, positioning, balance, transfers, safe use of walking aids, strength and gait.

A decline in movement should prompt clinical reassessment.

The answer is not always to force the joint harder. The distraction rate, pain, nerve tension and mechanical alignment may also need to be reviewed.

Warning signs

Emergency medical care should be sought without waiting for a routine response if there is:

• chest pain or sudden shortness of breath
• coughing blood, fainting or sudden deterioration
• a pale, cold, blue or severely painful foot
• rapidly increasing limb tightness with severe pain
• sudden loss of movement or marked new weakness
• uncontrolled bleeding
• confusion or a significant change in consciousness

The treating team should be contacted promptly for:

• fever, wound drainage or spreading redness
• increasing pin site pain or discharge
• new or progressive numbness, tingling or burning pain
• reduced ability to lift the foot or toes
• rapid loss of knee or ankle movement
• an increasing equinus position
• a fall, snap, unusual mechanical sound or change in limb shape
• unexpected controller or implant behaviour
• inability to complete the prescribed distraction
• a difference between intended distraction and radiographic progress
• pain that changes substantially or prevents previously possible rehabilitation

Early reporting does not mean that every symptom is a complication.

It allows the clinical team to identify a developing problem while it may still be reversible.

What happens if a complication develops?

The response depends on the cause and severity.

Treatment may involve:

• closer clinical observation
• additional imaging or blood tests
• changes to medication
• modification of weight bearing
• more intensive or altered physiotherapy
• splinting or bracing
• slowing or pausing distraction
• limited reversal of distraction
• reduction of the final target
• antibiotics or anticoagulation
• metabolic treatment
• bone grafting
• soft tissue release
• nerve decompression
• implant revision or replacement
• treatment of infection
• fracture fixation
• an unplanned return to surgery

A complication does not automatically mean that the treatment has failed. Many problems can be corrected when identified early.

It may, however, make the treatment longer and more demanding.

Some patients require formal Revision After Limb Lengthening or Reconstruction when bone healing, implant performance, alignment, infection, joint function or another unresolved problem requires further treatment.

In some situations, preserving joint movement, nerve function, alignment or bone health requires the clinical team to stop before the intended length has been reached.

That decision can be disappointing.

It can still be the medically correct decision.

Implant removal and late recovery

Many internal lengthening nails are intended to be removed after the regenerate has fully consolidated. The timing depends on the implant, bone healing and the patient’s clinical condition.

Removal is another operation.

It carries risks of anaesthesia, bleeding, infection, pain, nerve irritation, difficulty removing the screws or nail and fracture through areas temporarily weakened by the implant or screw holes.[12]

Activity may need to be restricted again after removal.

Complications can also appear late. Persistent stiffness, weakness, altered gait, scar sensitivity, chronic pain, loss of alignment and fracture should remain part of follow-up.

A favourable early radiograph does not establish the final result.

A note on the evidence

Most published evidence on elective cosmetic limb lengthening remains observational.

Patient selection, surgical techniques, implants, complication definitions, reporting methods and follow-up periods vary considerably. Older external fixation and combined techniques also cannot be treated as directly equivalent to modern internal lengthening systems.

This does not make the evidence unusable.

It means that a percentage from one publication should not be presented as a universal prediction for an individual patient. Risk must be interpreted in the context of the bone being lengthened, anatomy, implant, health, intended length, rehabilitation and the response that becomes visible during treatment.

Reliable procedure-specific incidence estimates are not available for several rare systemic events discussed in this guide, particularly venous thromboembolism and fat embolism syndrome. The same limitation applies to complex regional pain syndrome and mortality.

Their inclusion reflects recognised biological risk, reported occurrence and the consequences of missing them, not a claim that their frequency can be predicted precisely for an individual patient.[2,3,7,8,13]

The clinical standard

Cosmetic limb lengthening is not completed when the target length appears on an X-ray.

It is completed when the bone has healed, the joints move, the muscles control the limb, the nerves function, the patient walks naturally and normal life has been regained as far as possible.

No surgeon can remove every risk. No implant can replace patient selection, biological healing, physiotherapy or close clinical observation.

A newer or stronger device may improve part of the treatment, but it does not make the human body predictable.

The surgeon has responsibilities. The patient also has responsibilities. This is a prolonged clinical collaboration.

At the same time, a complication should never automatically be attributed to patient behaviour. Problems can occur despite good surgery and full participation.

At ILLRC, the treatment target is not defined by the maximum capacity of an implant or by a number selected before surgery.

It is defined by the greatest length that can be achieved while protecting bone healing, alignment, joint movement, neurological function and the patient’s long-term ability to walk.

The purpose is not merely to make a healthy person taller.

The purpose is to keep that person healthy.

Selected Medical References

1. Paley D. Problems, obstacles, and complications of limb lengthening by the Ilizarov technique. Clin Orthop Relat Res. 1990;(250):81–104. PubMed PMID: 2403498
2. Giorgino R, Cornacchini J, Sillmann YM, et al. Aesthetic lower limb lengthening techniques: a systematic review of efficacy, complications, and patient satisfaction. J Orthop Surg Res. 2025;20:415. doi:10.1186/s13018-025-05808-x
3. Frost MW, Rahbek O, Traerup J, Ceccotti AA, Kold S. Systematic review of complications with externally controlled motorized intramedullary bone lengthening nails (FITBONE and PRECICE) in 983 segments. Acta Orthop. 2021;92(1):119–126. doi:10.1080/17453674.2020.1835321
4. Buksbaum J, Fragomen AT, Hoellwarth JS, et al. Bone Healing Index and Complications of a Magnetic Internal Lengthening Nail: A Retrospective Series of 286 Bone Lengthening Events. J Am Acad Orthop Surg Glob Res Rev. 2025;9(6). doi:10.5435/JAAOSGlobal-D-25-00118. PubMed PMID: 40456100
5. Kim SJ, Agashe MV, Song SH, Song HR. Fibula-related complications during bilateral tibial lengthening: 60 patients followed for mean 5 years. Acta Orthop. 2012;83(3):271–275. doi:10.3109/17453674.2012.665328
6. Simpson AHRW, Halliday J, Hamilton DF, Smith M, Mills K. Limb lengthening and peripheral nerve function: factors associated with deterioration of conduction. Acta Orthop. 2013;84(6):579–584. doi:10.3109/17453674.2013.859418
7. Iliadis AD, Timms A, Fugazzotto S, et al. Thromboprophylaxis in Intramedullary Limb Lengthening Surgery. Strategies Trauma Limb Reconstr. 2020;15(3):151–156. doi:10.5005/jp-journals-10080-1505. PubMed PMID: 34025795
8. Timon C, Keady C, Murphy CG. Fat Embolism Syndrome: A Qualitative Review of its Incidence, Presentation, Pathogenesis and Management. Malays Orthop J. 2021;15(1):1–11. doi:10.5704/MOJ.2103.001. PubMed PMID: 33880141
9. Fridberg M, Bue M, Rölfing JD, Kold S. Host Factors and Risk of Pin Site Infection in External Fixation: A Systematic Review Examining Age, Body Mass Index, Smoking, and Comorbidities Including Diabetes. J Limb Lengthen Reconstr. 2022;8(Suppl 3):S3–S15. doi:10.4103/jllr.jllr_32_21
10. Smolle MA, Leitner L, Böhler N, et al. Fracture, nonunion and postoperative infection risk in the smoking orthopaedic patient: a systematic review and meta-analysis. EFORT Open Rev. 2021;6(11):1006–1019. doi:10.1302/2058-5241.6.210058. PubMed PMID: 34909221
11. Kaleeny JD, Janis JE. Body Dysmorphic Disorder in Aesthetic and Reconstructive Plastic Surgery: A Systematic Review and Meta-Analysis. Healthcare (Basel). 2024;12(13):1333. doi:10.3390/healthcare12131333. PubMed PMID: 38998867
12. Frost MW, Kold S, Rahbek O, et al. Complications in Elective Removal of 271 Bone Lengthening Nails (FITBONE, PRECICE and STRYDE). Strategies Trauma Limb Reconstr. 2021;16(2):110–115. doi:10.5005/jp-journals-10080-1529. PubMed PMID: 34804227
13. Paley D, Debiparshad K, Balci H, Windisch W, Lichtblau C. Stature Lengthening Using the PRECICE Intramedullary Lengthening Nail. Tech Orthop. 2015;30(3):167–182. doi:10.1097/BTO.0000000000000140